Navidea Biopharmaceutical...

0.00
-0.00 (-100.00%)
At close: Feb 27, 2025, 3:00 PM
0.00
11.11%
Pre-market: Sep 03, 2024, 09:30 AM EDT

Corporate Segment Revenue

History

Quarter Value Change Growth
Dec 31, 2022 0 -7.52K -100.00%
Sep 30, 2022 7.52K -42.83K -85.07%
Dec 31, 2021 50.35K -138.58K -73.35%
Dec 31, 2020 188.93K 75.43K +66.45%
Sep 30, 2020 113.5K 104.58K +1172.44%
Jun 30, 2020 8.92K -65.22K -87.97%
Mar 31, 2020 74.14K -20.27K -21.47%
Mar 31, 2019 94.41K 88.9K +1614.95%
Dec 31, 2018 5.5K -309.64K -98.25%
Dec 31, 2017 315.14K 104.66K +49.73%
Sep 30, 2017 210.48K -307.9K -59.40%
Jun 30, 2017 518.38K -52.99K -9.27%
Mar 31, 2017 571.36K -9.71M -94.44%
Sep 30, 2016 10.28M 3.83M +59.32%
Jun 30, 2016 6.45M 791.91K +13.99%
Mar 31, 2016 5.66M -2.58M -31.31%
Dec 31, 2015 8.24M 3.24M +64.67%
Sep 30, 2015 5.01M 5.01M n/a
Jun 30, 2015 0 n/a n/a
Mar 31, 2015 0 n/a n/a